farnesol has been researched along with Alzheimer Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wang, X; Wang, Y; Yan, L; Zhao, L; Zhu, Y | 1 |
1 other study(ies) available for farnesol and Alzheimer Disease
Article | Year |
---|---|
Neuroprotective Effect of S-trans, Trans-farnesylthiosalicylic Acid via Inhibition of RAS/ERK Pathway for the Treatment of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models, Animal; Doublecortin Protein; Extracellular Signal-Regulated MAP Kinases; Farnesol; Injections, Intraperitoneal; Male; MAP Kinase Signaling System; Maze Learning; Mice; Mice, Inbred ICR; Molecular Structure; Neuroprotective Agents; ras Proteins; Salicylates; Stereoisomerism | 2019 |